AstraZeneca
01.13.21
EMA Receives Conditional Marketing Request for AstraZeneca’s COVID-19 VaccineSource: FirstWord
11.30.20
UK Government Asks Regulator to Clear “Temporary Supply” of AstraZeneca’s COVID-19 VaccineSource: FirstWord
11.20.20
Data Confirm Immune Response From AstraZeneca’s COVID-19 Vaccine in ElderlySource: FirstWord
11.13.20
AstraZeneca’s Calquence Fails to Help Patients Hospitalized With COVID-19 Respiratory SymptomsSource: FirstWord
10.27.20
AstraZeneca’s COVID-19 Vaccine Produces Robust Immune Response in ElderlySource: FirstWord
10.22.20
Suspected Control Group Participant in AstraZeneca COVID-19 Vaccine Study Dies; Trial ContinuesSource: FirstWord
10.21.20
Sources Say US Study of AstraZeneca’s COVID-19 Vaccine May Restart This WeekSource: FirstWord
10.12.20
AstraZeneca to Test Long-Acting Antibody Treatment AZD7442 in COVID-19 TrialsSource: FirstWord